+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Anticoagulants Market (2023-2028) by Drug Class, Route of Administration and Geography, Impact of Covid-19 with Ansoff Analysis

  • PDF Icon


  • 197 Pages
  • January 2023
  • Region: Global
  • Infogence Global Research
  • ID: 5317270
The Global Anticoagulant Market is estimated to be USD 38.56 Bn in 2023 and is expected to reach USD 61.18 Bn by 2028, growing at a CAGR of 9.67%.

Market Dynamics

Market dynamics are forces that impact the prices and behaviors of the stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding growth and reducing the risks.

Market Segmentations

The Global Anticoagulant Market is segmented based on Route of Administration, Anticoagulant Drug, Drug Class, Application, and Geography.
  • By Route of Administration, the market is classified into Injectable Anticoagulants and Oral Anticoagulants.
  • By Anticoagulant Drug, the market is classified into Betrixaban, Dabigatran, Edoxaban / Rivaroxaban, and Eliquis.
  • By Drug Class, the market is classified into DTIs, Factor XA Inhibitors, Heparin, and Vitamin K Antagonists.
  • By Application, the market is classified into Atrial fibrillation & Heart Attack, Deep Vein Thrombosis, Pulmonary Embolism, and Stroke.
  • By Geography, the market is classified into Americas, Europe, Middle East & Africa, and Asia-Pacific.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are AstraZeneca PLC, Athenex, Inc., Baxter Laboratories Pty Ltd., etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes a Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

The report presents a detailed Ansoff matrix analysis for the Global Anticoagulant Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.

The analyst analyses the Global Anticoagulant Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.

Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Anticoagulant Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth Market analysis using Porter's 5 forces model, PESTLE Analysis, and the Ansoff Matrix. In addition, the impact of COVID-19 and the impact of economic slowdown & impending recession on the Market are also featured in the Report
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains a competitive analysis using Positioning Quadrants, the analyst's competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including the parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the Global Anticoagulants Market

What is the estimated value of the Global Anticoagulants Market?

The Global Anticoagulants Market was estimated to be valued at $38.56 Billion in 2023.

What is the growth rate of the Global Anticoagulants Market?

The growth rate of the Global Anticoagulants Market is 9.6%, with an estimated value of $61.18 Billion by 2028.

What is the forecasted size of the Global Anticoagulants Market?

The Global Anticoagulants Market is estimated to be worth $61.18 Billion by 2028.

Who are the key companies in the Global Anticoagulants Market?

Key companies in the Global Anticoagulants Market include Akebia Therapeutics, Inc., Aspen Pharmacare Holdings Ltd., AstraZeneca PLC, Athenex, Inc., Baxter Laboratories Pty. Ltd., Bayer Ag, C.H. Boehringer Sohn AG & Ko. KG, Eli Lilly and Company and Mylan N.V..

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders

2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Analyst Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study

3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations, and Outlook

4 Market Dynamics
4.1 Drivers
4.1.1 Increasing Prevalence of Venous Thromboembolism and Cardiovascular Disorders
4.1.2 Growing Number of Elderly and Obese People
4.1.3 Increasing Acceptance of Novel Oral Anticoagulants
4.2 Restraints
4.2.1 Stringent Regulations Related to Drug Dosage and Clinical Approvals
4.3 Opportunities
4.3.1 Increasing R&D Investments In Novel Anticoagulation Therapeutics
4.3.2 Increasing Collaboration Activities and Development of Generic Drugs
4.4 Challenges
4.4.1 Potential Risk and Complications Associated Usage of Oral Anticoagulants

5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 PESTLE Analysis
5.4 Impact of COVID-19
5.5 Impact of Economic Slowdown & Impending Recession
5.6 Ansoff Matrix Analysis

6 Global Anticoagulant Market, By Route of Administration
6.1 Introduction
6.2 Injectable Anticoagulants
6.3 Oral Anticoagulants

7 Global Anticoagulant Market, By Anticoagulant Drug
7.1 Introduction
7.2 Betrixaban
7.3 Dabigatran
7.4 Edoxaban / Rivaroxaban
7.5 Eliquis

8 Global Anticoagulant Market, By Drug Class
8.1 Introduction
8.2 DTIs
8.3 Factor XA Inhibitors
8.4 Heparin
8.5 Vitamin K Antagonists

9 Global Anticoagulant Market, By Application
9.1 Introduction
9.2 Atrial fibrillation & Heart Attack
9.3 Deep Vein Thrombosis
9.4 Pulmonary Embolism
9.5 Stroke

10 Americas' Anticoagulant Market
10.1 Introduction
10.2 Argentina
10.3 Brazil
10.4 Canada
10.5 Chile
10.6 Colombia
10.7 Mexico
10.8 Peru
10.9 United States
10.10 Rest of Americas

11 Europe's Anticoagulant Market
11.1 Introduction
11.2 Austria
11.3 Belgium
11.4 Denmark
11.5 Finland
11.6 France
11.7 Germany
11.8 Italy
11.9 Netherlands
11.10 Norway
11.11 Poland
11.12 Russia
11.13 Spain
11.14 Sweden
11.15 Switzerland
11.16 United Kingdom
11.17 Rest of Europe

12 Middle East and Africa's Anticoagulant Market
12.1 Introduction
12.2 Egypt
12.3 Israel
12.4 Qatar
12.5 Saudi Arabia
12.6 South Africa
12.7 United Arab Emirates
12.8 Rest of MEA

13 APAC's Anticoagulant Market
13.1 Introduction
13.2 Australia
13.3 Bangladesh
13.4 China
13.5 India
13.6 Indonesia
13.7 Japan
13.8 Malaysia
13.9 Philippines
13.10 Singapore
13.11 South Korea
13.12 Sri Lanka
13.13 Thailand
13.14 Taiwan
13.15 Rest of Asia-Pacific

14 Competitive Landscape
14.1 Competitive Quadrant
14.2 Market Share Analysis
14.3 Strategic Initiatives
14.3.1 M&A and Investments
14.3.2 Partnerships and Collaborations
14.3.3 Product Developments and Improvements

15 Company Profiles
15.1 Akebia Therapeutics, Inc.
15.2 Aspen Pharmacare Holdings Ltd.
15.3 AstraZeneca PLC
15.4 Athenex, Inc.
15.5 Baxter Laboratories Pty. Ltd.
15.6 Bayer Ag
15.7 C.H. Boehringer Sohn AG & Ko. KG
15.8 Eli Lilly and Company
15.9 Johnson & Johnson
15.10 Mylan N.V.
15.11 Novartis Ag
15.12 Pfizer Inc.
15.13 Sandoz International GmbH
15.14 Sanofi SA
15.15 Teva Pharmaceutical Industries Ltd.

16 Appendix
16.1 Questionnaire

Companies Mentioned

  • Akebia Therapeutics, Inc.
  • Aspen Pharmacare Holdings Ltd.
  • AstraZeneca PLC
  • Athenex, Inc.
  • Baxter Laboratories Pty. Ltd.
  • Bayer Ag
  • C.H. Boehringer Sohn AG & Ko. KG
  • Eli Lilly and Company
  • Johnson & Johnson
  • Mylan N.V.
  • Novartis Ag
  • Pfizer Inc.
  • Sandoz International GmbH
  • Sanofi SA
  • Teva Pharmaceutical Industries Ltd.